Neonatal Staphylococcus aureus Bacteremia: A 12-Year Retrospective Study on Treatment Duration and Relapse
Authors:
- 22 July 2025
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (12) , 1216-1221
Abstract
Background: Antibiotic therapy for neonatal Staphylococcus aureus bacteremia (NSAB) is recommended for at least 14 days. However, this recommendation is based on very limited data. This study aimed to compare NSAB relapses between patients treated for less than 14 days versus 14 days or more in neonatal intensive care units. Methods: This retrospective study was conducted in 3 neonatal intensive care units. All patients with a positive blood culture for S. aureus from January 2010 to December 2022 were included. Relapse was defined as the identification of S. aureus in a blood culture within 3 months after cessation of antibiotic therapy. Results: Of 169 patients with positive blood culture for S. aureus , 134 patients were included in the analysis. Fifteen (9%) were excluded because cultures were considered contamination, 19 (11%) because of death before completing treatment, and one because of missing data. The median gestational age was 28 weeks. One hundred patients (75%) had a central venous line. The median duration of antibiotic therapy was 8 days (interquartile range: 6–9) in the P = 0.775). Conclusions: In this cohort, no increased risk of NSAB relapse was observed with treatment durations of less than 14 days. Further trials are necessary to determine the optimal treatment duration for NSAB.Keywords
This publication has 26 references indexed in Scilit:
- Pharmacovigilance of nephrotoxic drugs in neonates: the Pottel method for acute kidney injury detection in ELBW neonatesPediatric Nephrology, 2024
- The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus PrevalenceClinical Infectious Diseases, 2023
- Antibiotic therapy for osteoarticular infections in 2023: Proposals from the Pediatric Infectious Pathology Group (GPIP)Infectious Diseases Now, 2023
- A retrospective study (2001–2017) of acute and chronic morbidity and mortality associated with Staphylococcus aureus bacteraemia in a tertiary neonatal intensive care unitIrish Journal of Medical Science (1971 -), 2019
- Neonatal sepsisThe Lancet, 2017
- Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus aureus bacteraemiaJournal of Hospital Infection, 2015
- Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopyJournal of Allergy and Clinical Immunology, 2011
- Pediatric and NeonatalStaphylococcus aureusBacteremia Epidemiology, Risk Factors, and OutcomeInfection Control & Hospital Epidemiology, 2009
- Staphylococcus aureus bacteraemia in children and neonates: A 10 year retrospective reviewJournal of Infection, 2006
- Staphylococcus aureus Bacteremia: Compliance with Standard Treatment, Long-term Outcome and Predictors of RelapseScandinavian Journal of Infectious Diseases, 2003